日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Circulating tumor DNA level is associated with time to clinical recurrence in Merkel cell carcinoma: Implications for patient management

循环肿瘤DNA水平与默克尔细胞癌临床复发时间相关:对患者管理的启示

Akaike, Tomoko; Thakuria, Manisha; Silk, Ann W; Hippe, Daniel S; Ch'en, Peter Y; Park, Song Youn; Urman, Nicole M; Chiu, Meliea W; Kim, Hannah; Kim, Emily Y; Hall, Evan T; Bhatia, Shailender; Reddy, Sunil; Krainock, Michael; Aleshin, Alexey; Choi, Jacob S; Tsai, Kenneth Y; Yom, Sue S; Yu, Siegrid S; Choi, Jaehyuk; Chandra, Sunandana; Nghiem, Paul T; Zaba, Lisa C

Steroid-sparing strategies for managing immune-related adverse events

减少类固醇用量的策略在管理免疫相关不良事件中的作用

Huang, Jennifer J; YousefiAsl, Maryam; Singh, Namrata; Grivas, Petros; Bhatia, Shailender

The Effect of COVID-19 During Pregnancy on Obstetric and Neonatal Outcomes: A Retrospective Case-Control Study

妊娠期新冠肺炎对产科和新生儿结局的影响:一项回顾性病例对照研究

McDuff, Laura; de Gouveia Belinelo, Patricia; Lawrance, Simon; Mehta, Shailender; Sunanda, Gargeswari

Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data

数据在哪里?免疫检查点抑制剂停药后延迟和慢性免疫相关不良事件的监测和管理:来自SITC的专家对生存期护理和长期数据需求的见解

Flores, Tessa F; Tonorezos, Emily S; Bhatia, Shailender; Brahmer, Julie R; Cappelli, Laura C; Cooper, Monica; Davies, Marianne; Guild, Samantha; Gunturu, Krishna; Haanen, John B A G; Johnson, Douglas B; Lacouture, Mario E; Leidner, Rom; Mitchell, Sandra; Moledina, Dennis G; Moslehi, Javid; Naidoo, Jarushka; Obeid, Michel; Postow, Michael; Puzanov, Igor; Reid, Mary E; Santomasso, Bianca D; Schadendorf, Dirk; Silk, Ann W; Sullivan, Ryan J; Walunas, Theresa; Wang, Yinghong; Ascierto, Paolo A; Ernstoff, Marc S

Nivolumab With or Without Ipilimumab in Patients With Recurrent or Metastatic Merkel Cell Carcinoma: A Nonrandomized, Open-Label, International, Multicenter Phase I/II Study

纳武利尤单抗联合或不联合伊匹木单抗治疗复发或转移性默克尔细胞癌患者:一项非随机、开放标签、国际多中心 I/II 期研究

Bhatia, Shailender; Topalian, Suzanne L; Sharfman, William; Meyer, Tim; Steven, Neil; Lao, Christopher D; Fariñas-Madrid, Lorena; Devriese, Lot A; Moore, Kathleen; Ferris, Robert L; Honma, Yoshitaka; Elias, Ileana; Srirangam, Anjaiah; Garnett-Benson, Charlie; Lee, Michelle; Nghiem, Paul

Improved survival at the population level for patients with advanced Merkel cell carcinoma following availability of immunotherapy

免疫疗法的出现提高了晚期默克尔细胞癌患者的群体生存率。

Paulson, Kelly G; Park, Song Y; Bhatia, Shailender; Hippe, Daniel S; Nghiem, Paul

Real-world outcomes of patients receiving salvage therapies for immune checkpoint inhibitor-resistant Merkel cell carcinoma: a rationale for future clinical trials

免疫检查点抑制剂耐药性默克尔细胞癌患者接受挽救性治疗的真实世界结果:未来临床试验的理论依据

Ch'en, Peter Y; Zhang, Yuzheng; Hippe, Daniel S; Akaike, Tomoko; Miller, Natalie J; Church, Candice; Lachance, Kristina; Finberg, Ariel; Gooley, Theodore; Hall, Evan; Bhatia, Shailender; Nghiem, Paul

Phase 1b/2 study evaluating safety, efficacy and immune effects of TLR9 agonist cavrotolimod with anti-PD-1 antibodies among patients with advanced solid tumors

一项评估 TLR9 激动剂 cavrotolimod 与抗 PD-1 抗体联合治疗晚期实体瘤患者的安全性、有效性和免疫效应的 1b/2 期研究

Milhem, Mohammed M; Wise-Draper, Trisha M; Chandra, Sunandana; Hanna, Glenn J; Laux, Douglas E; Medina, Theresa M; Ansstas, George; Daud, Adil; Kelly, Ciara M; O'Day, Steven J; Perez, Cesar A; Wong, Michael K; Friedlander, Philip A; Kristedja, Timothy S; Burgess, Melissa A; Cowey, C Lance; Hanks, Brent A; Weight, Ryan M; Daniel, Weston L; Feltner, Douglas E; Mix, Scott; Sindelar, Laurel; Bexon, Alice S; Bexon, Martin F; Michel, Robert E; Bhatia, Shailender

Phase II study of retifanlimab in patients with recurrent locally advanced or metastatic Merkel cell carcinoma (POD1UM-201)

retifanlimab治疗复发性局部晚期或转移性默克尔细胞癌患者的II期研究(POD1UM-201)

Grignani, Giovanni; Rutkowski, Piotr; Lebbé, Céleste; Guida, Michele; Gaudy-Marqueste, Caroline; Spagnolo, Francesco; Burgess, Melissa; Morano, Federica; Montaudié, Henri; Depenni, Roberta; Spada, Francesca; Yeung, Cecilia C S; Pulini, Jennifer; Cornfeld, Mark; Tian, Chuan; Bhatia, Shailender

Risk of disease progression after discontinuing immunotherapy in 105 patients with Merkel cell carcinoma who responded to PD-1 pathway blockade

105 例对 PD-1 通路阻断疗法有反应的默克尔细胞癌患者停止免疫治疗后疾病进展的风险

Tachiki, Lisa; Moshiri, Yasman; Hippe, Daniel S; Gong, Emily; Zawacki, Lauren; Pulliam, Thomas; Lachance, Kristina; Church, Candice; Fu, Alex; Huynh, Emily; Remington, Allison J; Harikrishnan, Nikhil; Bierma, Marika; Doolittle-Amieva, Coley; Akaike, Tomoko; Park, Song Y; Alexander, Nora A; Zaba, Lisa; Bhatia, Shailender; Nghiem, Paul T